Stock SHL SIEMENS HEALTHINEERS AG
Add to a list
To use this feature you must be a member
Log inSign up

Financials Siemens Healthineers AG Deutsche Boerse AG

Equities

SHL

DE000SHL1006

Advanced Medical Equipment & Technology

Market Closed - Deutsche Boerse AG
Other stock markets
 11:08:44 2024-06-28 EDT 		5-day change 1st Jan Change
53.84 EUR -2.36% Intraday chart for Siemens Healthineers AG +1.55% +1.39%
06-28 German Shares Advance Ahead of French Snap Elections MT
06-26 SIEMENS HEALTHINEERS : Barclays keeps its Buy rating ZD

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 36,067 41,088 63,053 49,516 53,731 60,029 - -
Enterprise Value (EV) 1 39,241 45,979 74,121 61,565 68,749 71,903 70,554 69,095
P/E ratio 23 x 27.4 x 35.8 x 24.5 x 35.8 x 29.9 x 23.6 x 20.1 x
Yield 2.22% 2.09% 1.51% 1.92% 1.98% 1.9% 2.31% 2.56%
Capitalization / Revenue 2.48 x 2.84 x 3.5 x 2.28 x 2.48 x 2.65 x 2.48 x 2.32 x
EV / Revenue 2.7 x 3.18 x 4.12 x 2.84 x 3.17 x 3.17 x 2.91 x 2.67 x
EV / EBITDA 13.4 x 16.4 x 20.5 x 14.4 x 18.6 x 15.9 x 13.3 x 11.8 x
EV / FCF 37.8 x 33.5 x 32.8 x 37.3 x 53.7 x 30 x 23.2 x 21 x
FCF Yield 2.65% 2.98% 3.05% 2.68% 1.86% 3.34% 4.31% 4.77%
Price to Book 3.69 x 3.07 x 3.79 x 2.51 x 2.96 x 3.18 x 2.96 x 2.74 x
Nbr of stocks (in thousands) 999,223 1,072,798 1,122,335 1,118,252 1,119,394 1,115,788 - -
Reference price 2 36.10 38.30 56.18 44.28 48.00 53.80 53.80 53.80
Announcement Date 19-11-04 20-11-02 21-11-04 22-11-09 23-11-08 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 14,518 14,460 17,997 21,714 21,680 22,673 24,250 25,837
EBITDA 1 2,920 2,796 3,612 4,269 3,692 4,525 5,316 5,870
EBIT 1 2,300 2,230 3,142 3,655 3,081 3,541 4,218 4,741
Operating Margin 15.84% 15.42% 17.46% 16.83% 14.21% 15.62% 17.39% 18.35%
Earnings before Tax (EBT) 1 2,193 1,954 2,404 2,800 1,928 2,730 3,540 4,150
Net income 1 1,567 1,411 1,727 2,038 1,509 2,017 2,556 3,000
Net margin 10.79% 9.76% 9.6% 9.39% 6.96% 8.9% 10.54% 11.61%
EPS 2 1.570 1.400 1.570 1.810 1.340 1.798 2.282 2.677
Free Cash Flow 1 1,038 1,371 2,259 1,652 1,281 2,399 3,044 3,293
FCF margin 7.15% 9.48% 12.55% 7.61% 5.91% 10.58% 12.55% 12.75%
FCF Conversion (EBITDA) 35.55% 49.03% 62.54% 38.7% 34.7% 53.01% 57.26% 56.1%
FCF Conversion (Net income) 66.24% 97.17% 130.8% 81.06% 84.89% 118.92% 119.07% 109.78%
Dividend per Share 2 0.8000 0.8000 0.8500 0.8500 0.9500 1.021 1.241 1.378
Announcement Date 19-11-04 20-11-02 21-11-04 22-11-09 23-11-08 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales 1 5,068 5,460 10,528 5,186 6,000 5,077 5,346 5,201 6,056 5,176 5,435 5,536 6,466 - - -
EBITDA 1 - 1,116 - 938 1,211 - - - - 885 917 1,115 1,480 - - -
EBIT 1 898 980 1,879 765 1,011 647 681 740 1,013 742 822 835.3 1,133 - - -
Operating Margin 17.72% 17.95% 17.85% 14.75% 16.85% 12.74% 12.74% 14.23% 16.73% 14.34% 15.12% 15.09% 17.53% - - -
Earnings before Tax (EBT) 1 661 - - - - - - - - 543 541 589.6 891.8 - - -
Net income 1 466 579 - 363 630 421 105 451 537 431 426 510.8 682.6 - - -
Net margin 9.19% 10.6% - 7% 10.5% 8.29% 1.96% 8.67% 8.87% 8.33% 7.84% 9.23% 10.56% - - -
EPS 2 0.4100 0.5100 - 0.3200 0.5600 0.3800 0.4700 0.4000 0.4800 0.3800 0.3800 0.4493 0.6217 - - -
Dividend per Share 2 - - - - 0.8500 - - - 0.9500 - - - 1.001 - - -
Announcement Date 22-02-03 22-05-04 22-05-04 22-08-03 22-11-09 23-02-02 23-05-16 23-08-02 23-11-08 24-02-01 24-05-07 - - - - -
1EUR in Million2EUR
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 3,174 4,891 11,068 12,049 15,018 11,873 10,525 9,065
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.087 x 1.749 x 3.064 x 2.822 x 4.068 x 2.624 x 1.98 x 1.544 x
Free Cash Flow 1 1,038 1,371 2,259 1,652 1,281 2,399 3,044 3,293
ROE (net income / shareholders' equity) 17% 14.3% 15.5% 14.3% 12.8% 12.8% 14.7% 15.6%
ROA (Net income/ Total Assets) 7.61% 6.07% 6.64% 5.65% 4.72% 4.65% 5.69% 6.44%
Assets 1 20,594 23,262 26,009 36,049 32,002 43,401 44,928 46,587
Book Value Per Share 2 9.790 12.50 14.80 17.70 16.20 16.90 18.20 19.60
Cash Flow per Share 2 1.620 1.910 2.670 2.220 1.880 2.940 3.750 3.840
Capex 1 579 557 674 852 838 924 973 1,053
Capex / Sales 3.99% 3.85% 3.75% 3.92% 3.87% 4.08% 4.01% 4.08%
Announcement Date 19-11-04 20-11-02 21-11-04 22-11-09 23-11-08 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Siemens Healthineers AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
53.8 EUR
Average target price
60.62 EUR
Spread / Average Target
+12.67%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
DANAHER CORPORATION Stock Danaher Corporation
+8.00% 185B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+31.86% 158B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+33.21% 113B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+21.14% 55.66B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+0.11% 48.41B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-6.76% 37.82B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+0.78% 35.57B
RESMED, INC. Stock ResMed, Inc.
+11.28% 28.12B
PHILIPS NV Stock Philips NV
+15.70% 23.58B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. SHL Stock
  4. SHL Stock
  5. Financials Siemens Healthineers AG